Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Cinclus Pharma secured $26.5M in capital funding.

Cinclus Pharma secured $26.5M in capital funding.

Biotech Health services Pharma

Sweden

Investments

05 March 2020

Share:

Cinclus Pharma (company)

Sweden

Biotech Health services Pharma

Total investments received (USD): 50.57m

Round value (USD): 26.48m

Round investors: AP4 - Fjärde AP-fonden Bengt Julander Jonas Sjögren Recipharm Venture Fund

Company: Cinclus Pharma

Industry: Biotech Health services Pharma

Related deals

Gesynta announced closing a $21M investment round led by Hadean Ventures.

Health services Pharma

Sweden

Norway

Investments 07 July 2020

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top